EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough

Empagliflozin is the first treatment to produce an unequivocal, hard-endpoint benefit in patients with heart failure with preserved ejection fraction, a practice-changing result.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news